<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 6: Biomedical Research: Gut-Brain Axis and Psychopharmacology</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Research/Medical */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #3b82f6;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸ”¬';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e40af;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .content-list {
            font-size: 17px;
            margin: 20px 0;
            padding-left: 24px;
        }

        .content-list li {
            margin-bottom: 14px;
            line-height: 1.7;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #daeaff 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #1e3a8a;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            margin-bottom: 8px;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fffaf0;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            border-left: 4px solid #22c55e;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            padding: 30px;
            border-radius: 12px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            border-top: 1px solid #eee;
            padding: 30px 0;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .ref-list {
            list-style: none;
            padding: 0;
        }

        .ref-list li {
            margin-bottom: 10px;
            line-height: 1.5;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.6;
            margin-bottom: 10px;
        }

        .alert-box {
            padding: 20px;
            border-radius: 10px;
            margin: 25px 0;
            border-left: 5px solid;
        }

        .alert-box.warning {
            background-color: #fff7ed;
            border-left-color: #f97316;
            color: #9a3412;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 19: L2: Research & Evidence</p>
            <h1 class="lesson-title">Biomedical Research: Gut-Brain Axis and Psychopharmacology</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 6 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Gut-Brain Axis (GBA)</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Fecal Microbiota Transplantation</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Evidence-Based Psychopharmacology</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Emerging Biological Targets</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Nutritional Interventions</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Debunking Pseudoscience</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the bidirectional mechanisms of the Gut-Brain Axis in neurodivergent populations.</li>
                <li>Evaluate the efficacy and safety data of FDA-approved pharmacological interventions.</li>
                <li>Critically appraise emerging research on oxytocin, vasopressin, and GABA-modulators.</li>
                <li>Distinguish between evidence-based nutritional support and non-evidence-based biomedical "cures."</li>
                <li>Identify the ethical boundaries of the Support Specialist when navigating biomedical discussions.</li>
            </ul>
        </div>

        <p>In our previous lessons, we explored the <span class="highlight">neurobiological architecture</span> and the genetic landscape of autism. However, the brain does not exist in a vacuum. As practitioners, we must understand that the biological profile of an autistic individual is often shaped by systemic factors, most notably the <span class="highlight">Gut-Brain Axis</span> and the influence of exogenous chemical interventions.</p>

        <p>This lesson moves from the "why" of neurobiology to the "how" of biomedical intervention. We will examine what the current literature saysâ€”and does not sayâ€”about medications, supplements, and the microbiome, ensuring you can provide evidence-based guidance while avoiding the pitfalls of pseudoscience.</p>

        <h2 id="section1">1. The Gut-Brain Axis (GBA): Bidirectional Signaling</h2>
        <p>The Gut-Brain Axis refers to the complex, <span class="highlight">bidirectional communication network</span> linking the enteric nervous system (ENS) and the central nervous system (CNS). This communication occurs via three primary pathways: the Vagus nerve, the immune system (cytokines), and microbial metabolites (short-chain fatty acids).</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">46-84%</span>
                    <span class="stat-label">Autistic individuals with GI symptoms</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">4.4x</span>
                    <span class="stat-label">Increased likelihood of GI distress vs. peers</span>
                </div>
            </div>
        </div>

        <p>Research suggests that dysbiosisâ€”an imbalance in gut bacteriaâ€”may contribute to the severity of certain autistic traits, particularly those related to anxiety and sensory processing. For example, a lower abundance of <i>Prevotella</i> and <i>Bifidobacterium</i> has been frequently noted in autistic cohorts compared to neurotypical controls.</p>

        <h2 id="section2">2. Microbiome Diversity & Fecal Microbiota Transplantation (FMT)</h2>
        <p>Perhaps the most provocative area of current biomedical research is <span class="highlight">Microbiota Transfer Therapy (MTT)</span>. Unlike standard probiotics, which introduce transient bacteria, MTT (or FMT) involves transferring a full spectrum of commensal bacteria from a healthy donor.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The Impact of MTT</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Client:</strong> Leo (Age 9), presenting with chronic constipation, high anxiety, and frequent meltdowns. Traditional behavioral interventions had plateaued.</p>
                <p><strong>Intervention:</strong> Leo participated in a clinical trial for Microbiota Transfer Therapy (FMT). His gut microbiome diversity was measured before and after the 8-week protocol.</p>
                <p><strong>Outcome:</strong> A 2-year follow-up study (Kang et al., 2019) showed that Leo and other participants maintained a 58% reduction in GI symptoms. Remarkably, core autism trait scores (SRS-2) decreased by 47% from baseline, suggesting that stabilizing the gut environment may lower the "biological noise" that exacerbates sensory and emotional distress.</p>
            </div>
        </div>

        <h2 id="section3">3. Evidence-Based Psychopharmacology: FDA-Approved Interventions</h2>
        <p>It is critical to clarify that there are currently <strong>no medications</strong> that "treat" the core social communication features of autism. Pharmacological intervention is primarily used to manage co-occurring symptoms that impact quality of life.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Medication</th>
                        <th>Indication</th>
                        <th>Effect Size (d)</th>
                        <th>Key Side Effects</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Risperidone</strong></td>
                        <td>Irritability, Agitation, Self-Injury</td>
                        <td>0.75 - 1.1 (Large)</td>
                        <td>Weight gain, Sedation, Prolactin elevation</td>
                    </tr>
                    <tr>
                        <td><strong>Aripiprazole</strong></td>
                        <td>Irritability, Aggression</td>
                        <td>0.65 - 0.9 (Medium-Large)</td>
                        <td>Akathisia, Metabolic changes, Somnolence</td>
                    </tr>
                    <tr>
                        <td><strong>Stimulants (MPH)</strong></td>
                        <td>Co-occurring ADHD symptoms</td>
                        <td>0.5 - 0.6 (Medium)</td>
                        <td>Reduced appetite, Sleep disturbance, Irritability</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>The <span class="highlight">Effect Size</span> (Cohen's d) is a crucial metric here. While Risperidone shows a "Large" effect size for irritability, the trade-off is often significant metabolic side effects. As a Support Specialist, your role is to help families track data on these trade-offs using <i>The Method's</i> observation protocols.</p>

        <h2 id="section4">4. Emerging Targets: Oxytocin, Vasopressin, and GABA</h2>
        <p>Current research is shifting away from broad-spectrum antipsychotics toward targeted <span class="highlight">neuromodulators</span>. These seek to address the "Excitatory/Inhibitory (E/I) imbalance" often cited in autistic neurology.</p>

        <ul class="content-list">
            <li><strong>Oxytocin (OXT):</strong> Often called the "social hormone," intranasal OXT trials have shown mixed results. A 2021 large-scale study (n=290) found no significant difference between OXT and placebo in social interaction scores, though subgroup analysis suggests it may benefit those with specific OXT-receptor genotypes.</li>
            <li><strong>Vasopressin (V1a) Antagonists:</strong> Balovaptan is currently being studied for its potential to improve social communication by modulating the vasopressin system, which is closely linked to social bonding and aggression.</li>
            <li><strong>GABA-Modulators:</strong> Since many autistic individuals show reduced GABAergic inhibition, drugs like Arbaclofen have been trialed to "quiet" the over-excited brain, though results in Phase III trials have been inconsistent.</li>
        </ul>

        <h2 id="section5">5. Nutritional Interventions: GFCF and Omega-3s</h2>
        <p>Families frequently turn to dietary changes before medication. It is essential to distinguish between <span class="highlight">clinical evidence</span> and anecdotal reports.</p>

        <div class="key-terms-box">
            <p class="box-label">Key Concepts in Nutrition</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">GFCF Diet</p>
                    <p class="definition">Gluten-Free, Casein-Free. Hypothesized to reduce "opioid-like" peptides from wheat/dairy. Evidence remains weak for core traits but may help GI-specific distress.</p>
                </div>
                <div class="term-item">
                    <p class="term">Omega-3 Fatty Acids</p>
                    <p class="definition">Essential for neuronal membrane fluidity. Meta-analyses show small improvements in hyperactivity but negligible impact on social communication.</p>
                </div>
            </div>
        </div>

        <div class="alert-box warning">
            <strong>Practitioner Note:</strong> Restrictive diets (like GFCF) can lead to nutritional deficiencies (Calcium, Vitamin D) and increased social isolation. Always recommend consultation with a registered dietitian before significant dietary removal.
        </div>

        <h2 id="section6">6. Debunking Non-Evidence-Based "Treatments"</h2>
        <p>In the "L2" level of support, you will encounter families desperate for solutions who may be targeted by predatory "biomedical" providers. You must be prepared to provide the evidence against these harmful practices.</p>

        <div class="principle-card">
            <div class="principle-title">Chelation Therapy</div>
            <div class="principle-text">
                Based on the debunked theory that autism is caused by heavy metal poisoning. <strong>DANGER:</strong> Chelation can strip the body of essential minerals and has resulted in pediatric fatalities. There is zero evidence of efficacy for autism.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">Hyperbaric Oxygen Therapy (HBOT)</div>
            <div class="principle-text">
                The theory is that increased oxygen reduces brain inflammation. Multiple high-quality RCTs (Randomized Controlled Trials) have shown that HBOT is no more effective than room-air placebo for autistic traits.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">Stem Cell Therapy</div>
            <div class="principle-text">
                Marketed as a way to "repair" neural tissue. Current research is in its infancy, often unregulated, and extremely expensive. There is currently no robust evidence supporting its use as a standard of care.
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of biomedical research applications.</p>

            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">A parent asks if they should start their child on Risperidone to help with "social skills." Based on the evidence, what is the most accurate response?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Risperidone is FDA-approved for irritability and aggression, not for social communication skills. While it has a large effect size for managing distress, it does not target social cognition and carries significant metabolic side effects.
                </div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">What does the 2019 Kang et al. study suggest about the long-term effects of Microbiota Transfer Therapy (MTT)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The study found that the benefits to both GI symptoms and autistic traits were maintained for at least two years post-treatment, suggesting a lasting shift in the microbiome's ecological diversity.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>The Gut-Brain Link:</strong> GI distress is not just a co-morbidity; it is biologically linked to behavioral and emotional regulation through the GBA.</li>
                <li><strong>Medication Limits:</strong> Current FDA-approved meds (Risperidone/Aripiprazole) target irritability, not the core neurodivergent profile.</li>
                <li><strong>Evidence Quality:</strong> Always look for <i>Effect Size</i> and <i>Replication</i> in biomedical claims.</li>
                <li><strong>Safety First:</strong> Practices like chelation are not only non-evidence-based but are actively dangerous and unethical.</li>
                <li><strong>Specialist Role:</strong> We support the person, not "fix" the biology. Our role is to provide data so families can make informed, safe choices.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="ref-list">
                <li>Kang, D. W., et al. (2019). "Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota." <i>Scientific Reports</i>.</li>
                <li>Sikich, L., et al. (2021). "Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder." <i>New England Journal of Medicine</i>.</li>
                <li>McPheeters, M. L., et al. (2011). "A systematic review of medical treatments for children with autism spectrum disorders." <i>Pediatrics</i>.</li>
                <li>Vuong, H. E., & Hsiao, E. Y. (2017). "Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder." <i>Biological Psychiatry</i>.</li>
                <li>James, S., et al. (2011). "Chelation for autism spectrum disorder (ASD)." <i>Cochrane Database of Systematic Reviews</i>.</li>
                <li>Howes, O. D., et al. (2018). "Autism spectrum disorder: Consensus guidelines on assessment and treatment." <i>Journal of Psychopharmacology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Certified Autism & Neurodiversity Support Specialist</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Certification Program.</p>
        </footer>
    </div>
</body>

</html>